Accelerating Chemical Biology and early Drug Discovery by academic collaborative initiatives

Dr. Wolfgang Fecke
Director General,EU-OPENSCREEN, Berlin, Germany

Leveraging EU-wide screening capability to promote academic led drug-discovery
Professor Graeme Milligan
Acting Vice Principal and Head of College/ Gardiner Chair of Biochemistry (Institute of Molecular Cell & Systems Biology), University of Glasgow, Glasgow, United Kingdom

EU-OPENSCREEN - An open-access research infrastructure for chemical biology and early drug discovery
Dr Bahne Stechmann
Head of Operations & Scientific Strategy, EU-OPENSCREEN, Berlin, Germany

Sourcing of compounds from the chemistry community as a model to expose them to new targets
Professor Päivi Tammela
Professor at the Faculty of Pharmacy & Head of the FIMM High Throughput Biomedicine Unit, University of Helsinki, Helsinki, Finland

The Kærtor Foundation - A Galician initiative in open-innovation and public-private co-development in drug discovery
Professor Mabel Loza
Professor of Pharmacology & Coordinator of BioFarma Research Group, University of Santiago de Compostela, Santiago de Compostela, Spain

Small molecule inhibitors of the production of reactive oxygen species
Speaker to be confirmed
To be confirmed

Distributed, Open Chemistry Towards New Medicines on a Planetary Scale
Professor Matthew Todd
Professor of Drug Discovery, UCL School of Pharmacy, London, United Kingdom